Milestone achieved toward production of malaria treatment using synthetic biology and fermentation
Amyris Biotechnologies has successfully increased the production of amorphadiene to 25g/L through E. coli fermentations, a crucial step towards commercially producing artemisinin precursors. This achievement demonstrates the potential of synthetic biology and fermentation to create a consistent and affordable source of artemisinin for ...